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Abstract
Background: Exposure to fine ambient particulate matter (PM) has consistently been associated
with increased morbidity and mortality. The relationship between exposure to ultrafine particles
(UFP) and health effects is less firmly established. If UFP cause health effects independently from
coarser fractions, this could affect health impact assessment of air pollution, which would possibly
lead to alternative policy options to be considered to reduce the disease burden of PM. Therefore,
we organized an expert elicitation workshop to assess the evidence for a causal relationship
between exposure to UFP and health endpoints.
Methods: An expert elicitation on the health effects of ambient ultrafine particle exposure was
carried out, focusing on: 1) the likelihood of causal relationships with key health endpoints, and 2)
the likelihood of potential causal pathways for cardiac events. Based on a systematic peer-
nomination procedure, fourteen European experts (epidemiologists, toxicologists and clinicians)
were selected, of whom twelve attended. They were provided with a briefing book containing key
literature. After a group discussion, individual expert judgments in the form of ratings of the
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likelihood of causal relationships and pathways were obtained using a confidence scheme adapted
from the one used by the Intergovernmental Panel on Climate Change.
Results: The likelihood of an independent causal relationship between increased short-term UFP
exposure and increased all-cause mortality, hospital admissions for cardiovascular and respiratory
diseases, aggravation of asthma symptoms and lung function decrements was rated medium to high
by most experts. The likelihood for long-term UFP exposure to be causally related to all cause
mortality, cardiovascular and respiratory morbidity and lung cancer was rated slightly lower, mostly
medium. The experts rated the likelihood of each of the six identified possible causal pathways
separately. Out of these six, the highest likelihood was rated for the pathway involving respiratory
inflammation and subsequent thrombotic effects.
Conclusion: The overall medium to high likelihood rating of causality of health effects of UFP
exposure and the high likelihood rating of at least one of the proposed causal mechanisms
explaining associations between UFP and cardiac events, stresses the importance of considering
UFP in future health impact assessments of (transport-related) air pollution, and the need for
further research on UFP exposure and health effects.
Background
Epidemiological studies have in recent decades convinc-
ingly shown that exposure to ambient particulate air pol-
lution is associated with increased cardiovascular and
respiratory morbidity and mortality [1-3] as well as cancer
[1,4,5]. Particulate matter (PM) is a complex mixture, and
as yet much remains unknown about the agents within air
pollutant mixtures that cause the adverse health effects.
Recently, outcomes of toxicological and epidemiological
studies suggest that the ultrafine component of PM might
play a role in initiating or stimulating part of these health
effects [6]. Ultrafine particles (UFP; i.e. atmospheric parti-
cles with aerodynamic diameter of < 100 nm) make up
only 10% of the total mass of PM2.5, but in number UFP
dominate the PM mixture as they constitute up to 90% of
the aerosol. Therefore, UFP have a large number concen-
tration as well as a relatively large surface to volume ratio.
Ambient UFP are mainly combustion-derived being pro-
duced by the transport and industry sectors.
Currently, health effects related to UFP exposure have
been studied less extensively than effects of fine and
coarse PM. The mechanisms at cell and molecular level are
as yet only partly understood [1,2,6-14]. There are multi-
ple competing causal models and hypotheses. This
implies that uncertainty is not just related to what param-
eters to use in impact estimations, but more fundamen-
tally, about the assumed causal mechanisms themselves
[15]. One of the first hypotheses regarding the specific
working mechanism of UFP was posed by Seaton and co-
workers [16]. They suggested that a systemic inflamma-
tory response to particulate air pollution could be caused
by the large surface area of UFP. This might cause or aggra-
vate cardiovascular and other diseases. Since then, several
studies and reviews have been published about the poten-
tial mechanisms relating UFP to (cardiovascular) health
effects [1,2,4,6-8,10,11,13,14,17-19]. These studies have
elaborated on the hypothesis suggested by Seaton and
have also provided new theories about plausible path-
ways, including translocation of particles to the blood-
stream and subsequently to other organs [1,4,8,11], and
particles altering respiratory reflexes and acting on the
autonomic nervous system (ANS) [1]. All these processes
may eventually lead to a cardiac event, either by stimulat-
ing plaque rupture which can subsequently lead to throm-
bosis [20]; or by affecting the ANS potentially leading to
arrhythmia. The suggested causal mechanisms vary (sub-
stantially) between authors and it is not always evident
how plausible a specific hypothesized pathway is. How-
ever, it should be recognised that these different pathways
are not mutually exclusive. In addition, some (parts) of
these pathways may also underlie health effects related to
coarser PM fractions (e.g. airway inflammation), whereas
others are thought to be specific to UFP, such as transloca-
tion of particles into the blood or other organs.
Significant health gains could be achieved by implement-
ing policy measures to reduce air pollution. Health
Impact Assessments (HIA) are often carried out in order to
develop or evaluate such policies. These assessments need
information about causal relationships and concentra-
tion-response functions. However, for UFP no accepted
summary concentration-response function is available.
Moreover, there are hardly any long-term exposure studies
[6,7,12]. Therefore, these HIAs have often considered
PM2.5 or PM10 effects for which such knowledge is availa-
ble. The potential health effects of UFP have been largely
ignored in HIA. Omission of UFP in HIA may lead to an
under-estimation of the health impacts of e.g. policies
designed to reduce transport-related air pollution,Particle and Fibre Toxicology 2009, 6:19 http://www.particleandfibretoxicology.com/content/6/1/19
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because reductions of UFP concentrations may be more
substantial in response to these policies than reductions
in fine PM concentrations.
In order to judge the possibility to include UFP in HIA,
first an assessment of the likelihood of a causal relation-
ship between UFP exposure and relevant health endpoints
(e.g. cardiac events such as myocardial infarction) inde-
pendent from effects of coarser fractions of other compo-
nents of air pollution is required. Evidence for
pathophysiological mechanisms explaining these events
add to the biological plausibility of epidemiologically
observed associations and may give clues as to which
components of the mixture are important in causing
adverse health effects. Evidence on mechanisms can sub-
sequently help in formulating effective counter measures.
One way to address these problems in the absence of suf-
ficient published studies is to use expert judgment
approaches to assess the degrees of (dis)agreement
between different experts. We used an expert elicitation
workshop to assess the likelihood of causality, selected
causal pathways and concentration-response functions
for UFP.
Expert elicitation
Expert elicitation is a systematic approach to generate and
synthesize subjective judgments of relevant experts on a
subject where well-established knowledge has not yet
been developed due to uncertainty stemming form e.g.
insufficient, contradicting, low-quality or unattainable
data. The process seeks to make the (un)published knowl-
edge and wisdom of experts explicit and utilizable, based
on their accumulated experience and expertise, including
their insight into the limitations, strengths and weak-
nesses of the published knowledge and available data. A
formal expert elicitation in 2007 [21] quantified concen-
tration-response functions and uncertainty for PM2.5-
related mortality. Other (less formal) expert workshops
have for example focused on potential mechanisms and
methods for testing hypotheses on cardiovascular effects
of air pollution [13], and reviewed the evidence for cardi-
ovascular and neurodegenerative effects of ambient parti-
cles [4].
The primary aim of our two day expert elicitation was to
bring together epidemiologists, toxicologists and clini-
cians that are renowned for their expertise in the field of
health effects of UFP to examine the plausibility of causal
relationships existing between UFP exposure and health
effects. The secondary aim was to quantify concentration-
response functions. We chose a multidisciplinary
approach to allow for potentially different opinions in the
environmental health field and to promote synthesis of
knowledge and discussion. This paper describes the
results of the first day of the workshop, dealing with cau-
sality issues. The quantification of specified concentra-
tion-response functions is described in a separate paper
(Hoek et al., submitted).
Methods
Expert selection
Key European experts on UFP and health from clinical,
toxicological and epidemiological backgrounds were
selected in a two-step systematic peer-nomination. As a
first step, we approached nominators, inviting: (a) first,
second and last authors that had published at least two
papers within the field of UFP and health in peer-reviewed
journals (key words of literature search: ultrafine particles
or particle number concentration or PM0.1 or UFP and
epidemiology or health or effects or toxicology), as well as
(b) scientists that participated in the WHO systematic
review of air pollution and coordinators of leading EU
projects in this research field (based on information at
http://www.ec.europa.eu/research/). These nominators
were asked to nominate 5 toxicologists, 5 epidemiologists
and 5 clinicians who had, in their opinion, the educa-
tional background and/or experience to display both a
thorough understanding of results from the epidemiolog-
ical and toxicological literature addressing the relation-
ship between UFP and various health effects, and to be
able to evaluate these results in the context of other evi-
dence pertinent to air pollution and various health effects.
The nominators were allowed to nominate themselves.
For budgetary reasons, the nominated experts had to be
based in Europe.
As a second step, we invited the top 5 ranked scientists
within each of the three mentioned disciplines, based on
the responses from the 43 identified nominators. Only
one expert per research group was invited to attend.
Invited experts who did not agree or were unable to par-
ticipate were replaced with the next candidate from the list
within their discipline, provided that they were nomi-
nated by at least 5 nominators. The following experts (per
discipline in which they were nominated and in alphabet-
ical order) accepted and attended the workshop. Toxicol-
ogists: Prof. Dr. P. Borm, Prof. Dr. K. Donaldson, Prof. Dr.
W. G. Kreyling, Prof. Dr. V. Stone. Epidemiologists: Prof.
Dr. B. Brunekreef, Dr. F. Forastiere, Prof. Dr. J. Pekkanen,
Prof. Dr. E. Wichmann. Clinicians: Prof. Dr. J. Ayres, Prof.
Dr. S. Holgate, Prof. Dr. B. Nemery, Prof. Dr. A. Seaton.
Two other experts (one epidemiologist and one toxicolo-
gist) also accepted, but were eventually unable to attend.
The workshop was prepared by a team of the University of
Utrecht (Institute for Risk Assessment Sciences and Coper-
nicus Institute) and the Dutch National Institute for Pub-
lic Health and the Environment (RIVM) and consisted ofParticle and Fibre Toxicology 2009, 6:19 http://www.particleandfibretoxicology.com/content/6/1/19
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Anne Knol, Jeroen de Hartog, Hanna Boogaard, Pauline
Slottje, Jeroen van der Sluijs, Erik Lebret, Flemming Cas-
see and Gerard Hoek.
Protocol, briefing book and workshop structure
In order to plan and structure the expert elicitation and
produce transparent and traceable results, we developed a
formal protocol based on protocols used for similar work-
shops [21,22]. This protocol outlined the structure of the
expert elicitation sessions. In order to allow the experts to
prepare for the meeting, we composed a briefing book
with a reading guideline, references of 81 peer reviewed
studies on UFP and health, summary texts and tables of
the literature, preliminary graphical representations of the
potential causal mechanisms, plus two recent papers on
expert elicitation for PM2.5 [21,22]. This briefing book
comprised of most papers that were selected in the litera-
ture review, which was carried out by the team of RIVM
and University of Utrecht. Slightly less animal studies as
compared to epidemiological studies were included,
because some animal studies that were adequately sum-
marized by the provided toxicological reviews were not
included. Experts were specifically asked to check and
complement the literature.
The causal pathway diagrams as presented to the experts
have been added in the appendix. Both the protocol and
briefing book were distributed to the panel beforehand on
a pass-word protected temporary website, and were avail-
able to the experts during the meeting both on CD and as
hard copies. The workshop started with an introduction
by a member of the organizing team (JvdS) about the
process of expert elicitations, the ratings scales and poten-
tial heuristic biases related to expert judgements. It was
made clear to the experts that we did not necessarily aim
at reaching consensus among them, but rather at gaining
insight into the various prevailing opinions and underly-
ing assumptions and uncertainties.
The approach taken during the workshop, to evaluate
causal mechanisms relating UFP exposure to cardiac
events, is similar to 'group model building' (GMB) meth-
ods [23,24] for joint exploration of causal models. Three
types of tasks can be identified in GMB exercises [24,25]:
(1) 'divergent tasks': elicitation of information on what to
include in the model, e.g. gathering ideas on possible
causes, effects, and pathways; (2) 'convergent tasks': com-
bining the elicited information into a chart, model, collec-
tive problem description, or policy strategy; (3)
'evaluation phase': discussing and evaluating the model
that has been developed, and prioritizing issues for fur-
ther discussion or elaboration.
Workshop participants only performed task three. The
other two stages were performed by the research team.
Information about model components was collected
through literature review and two overview models were
created representing six different potential causal path-
ways. Participants evaluated these proposed pathways.
The experts were instructed to take account of the follow-
ing basic assumptions and restrictions. The focus was on
total UFP from atmospheric origin, without differentiat-
ing between different sources of UFP or different compo-
nents within the mixture (e.g. diesel, carbon black, fly
ash). Furthermore, we considered inhalation as the only
intake route, since it is thought to be the major portal of
entry of UFP into the human body [11]. Finally, we
focused specifically on the potential of UFP to cause effects
separately and independently from effects of coarser frac-
tions or other air pollution components. The morning ses-
sion of the meeting dealt with the likelihood of a causal
relationship between UFP exposure and various health
endpoints. The health endpoints were selected a priori
based on their relevancy for HIA, and therefore primarily
associated with health endpoints as studied in epidemiol-
ogy. During the session, the experts were given the oppor-
tunity to reflect on this a priori list and discuss adding or
dismissing specific health endpoints. In the afternoon ses-
sion, the likelihoods of six a priori selected causal mecha-
nisms associating UFP with cardiac events were examined.
We did not aim to discuss the specific details of particular
(patho)physiological processes or working mechanisms
within a particular pathway. Instead, we focused on the
likelihood of these six broadly defined pathways, based
upon previous reviews.
For clarity and to enhance inter-expert comparability, the
formulation of some questions was slightly refined during
the workshop, based on experts' suggestions. The final
questions for the morning session were formulated as fol-
lows: "Considering the evidence, how do you rate the likelihood
that short-term/long-term exposure to ultrafine particles at real-
istic ambient levels is causally related to health endpoint X?"
The questions on plausible causal mechanisms were asked
for cardiac events only, conditional on the existence of a
causal relationship, and independent of each other (i.e.
allowing for the possibility of singular as well as multiple
routes in parallel). These questions were posed as follows:
"Assuming a causal relationship between exposure to ultrafine
particles at realistic ambient levels and cardiac events, and con-
sidering the evidence, how do you rate the likelihood that these
events can be (partly) explained by pathway Y?". A low rating
could be given if any of the steps in the pathway was con-
sidered to be of little plausibility or importance.
Proposed mechanisms were evaluated using a so-called
'Delphi' technique [26]. The experts were asked to rate the
likelihoods of the various pathways using a number (0 –
4) according to a confidence scheme adapted from the
one used by inter alia the Intergovernmental Panel on Cli-
mate Change (IPCC) [27] (figure 1). For each question,Particle and Fibre Toxicology 2009, 6:19 http://www.particleandfibretoxicology.com/content/6/1/19
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the following steps were performed: (1) an individual rat-
ing, (2) an (anonymous) on-screen graphical presenta-
tion of these initial ratings, (3) a plenary discussion based
on this presentation, and (4) a final individual rating. We
thereby encouraged experts to first reflect upon their own
ideas, before sharing their knowledge and potentially
adjusting their ratings based on new insights. We favoured
group discussion over, for example, personal interviews,
in order to encourage inter-expert communication in a
multidisciplinary setting.
The questions related to causal pathways were preceded
by a plenary discussion and some refinement of the
graphical representations of these pathways. Experts were
explicitly asked to provide both written and oral motiva-
tion for their initial and final ratings, e.g. on which evi-
dence and assumptions these were primarily based. The
results of the final ratings and a synopsis of the motiva-
tion and major points of discussion are described in this
paper.
Results
The results of this study are divided into three sections: 1)
the likelihood of a causal relationship between short-term
UFP exposure and selected health outcomes; 2) the likeli-
hood of a causal relationship between long-term UFP
exposure and selected health outcomes; 3) the likelihood
of selected potential causal mechanisms for UFP exposure
and acute cardiac events. Figures 2, 3 and 4 show the num-
bers of experts providing specific likelihood ratings, which
are expressed as categories ranging from very low to very
high.
1. Likelihood of causal relationships between short-term 
UFP exposure and health effects
The results of the final expert ratings considering the like-
lihood that short-term UFP exposure is causally related to
selected health endpoints are presented in figure 2.
All-cause mortality
Ratings of the likelihood of causality ranged from
medium (n = 7) to very high. The experts giving higher rat-
ings argued that underlying causal mechanisms for cardi-
ovascular effects are very plausible and documented in
toxicological studies, and that independent and stable
effects of UFP have been found in epidemiological studies
(quoted references included [28-30]). The ratings were
based on the notion that short-term variation in all-cause
mortality is primarily driven by variation in cardiovascular
mortality. Evidence of health effects from other compo-
nents such as NO2 and CO that are correlated with UFP
raised their confidence. Recent unpublished work from
London further raised confidence among some experts.
Lower ratings were motivated by the fact that most studies
rely on limited, rather incoherent and mainly indirect
data from e.g. PM2.5 studies. Additionally, exposure mis-
classification, lack of evidence for independent effects of
UFP and lack of correction for publication bias were men-
tioned by some experts. Data from Rome and Aberdeen
that were unpublished at the time of rating were also men-
tioned to support lower ratings (data from Aberdeen are
currently published in [31], a manuscript about the data
from Rome is submitted (Belleudi et al., submitted)).
Cardiovascular and respiratory hospital admissions
The likelihood of a causal relationship between short-
term UFP exposure and cardiovascular or respiratory hos-
pital admissions was rated from low to high, with overall
slightly higher ratings for cardiovascular hospital admis-
sions (figure 2). For the latter, some experts considered
several studies [32-34] to have clearly shown mechanistic
relationships, with good evidence from epidemiological
and human controlled exposure studies. The mechanisms
for cardiovascular effects were generally considered very
plausible. Lower ratings were mainly motivated by the
limited number of studies, with mixed and controversial
results. Independent effects of UFP were considered diffi-
cult to separate from other components of air pollution.
For respiratory hospital admissions, similar motivations
were given. Most experts considered respiratory effects to
be mechanistically plausible, although some argued UFP
effects to be less convincing than effects for larger fractions
(e.g. PM2.5) [35,36].
Level of confidence scheme used for likelihood rating, adapted from [27] Figure 1
Level of confidence scheme used for likelihood rating, adapted from [27].Particle and Fibre Toxicology 2009, 6:19 http://www.particleandfibretoxicology.com/content/6/1/19
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Respiratory symptoms
The respiratory outcomes considered were cough, aggra-
vation of symptoms in asthma patients, and decrements
in lung function. Of these, aggravation of symptoms in
asthma patients was generally rated highest and cough
lowest (figure 2). For cough, likelihood ratings ranged
from (very) low to medium (n = 6). Low ratings were
partly given because cough was considered to be a very
non-specific endpoint which functions as an indicator of
a range of health endpoints of varying severity. Also, sev-
eral experts assessed that there is little evidence available
for an association between UFP and cough, and cough
was considered more likely to be related to larger PM frac-
tions (high dust exposure). The experts generally consid-
ered aggravation of symptoms in asthma patients exposed
to UFP highly likely (likelihood ratings ranging from low
to high (n = 8)), even though they judged the clinical evi-
dence to be rather inconsistent. Mechanistically, aggrava-
tion of symptoms was believed to be very plausible due to
the high susceptibility of asthma patients, in which UFP
may further irritate already stimulated cells. A study show-
ing increased medication use [37], mechanistic studies
among children in Helsinki [38] and respiratory effects
shown in a London study [39] were quoted as references
to support high ratings. Decrements in lung function
(likelihood ratings medium (n = 7) to very high) were,
like cough, considered to be a rather non-specific end-
point. Some studies [39-42] were quoted that support an
effect of UFP on lung function.
2. Likelihood of causal relationships between long-term 
UFP exposure and health effects
The results of the final expert ratings considering the like-
lihood of long-term UFP exposure to be causally related to
various health endpoints are presented in figure 3.
All cause mortality
A causal association between long-term UFP exposure and
all-cause mortality was generally considered of medium
(n = 7 out of 12) likelihood by the experts (likelihood rat-
Final likelihood ratings for health endpoints being causally related to short-term UFP exposure Figure 2
Final likelihood ratings for health endpoints being causally related to short-term UFP exposure.Particle and Fibre Toxicology 2009, 6:19 http://www.particleandfibretoxicology.com/content/6/1/19
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ings ranging from low to very high). The ratings of these
long-term exposure effects were overall only slightly lower
than for the corresponding short-term exposure effects.
Evidence was deemed mostly indirect, based on associa-
tions between other PM fractions or other exposure varia-
bles and mortality. Nevertheless, some experts indicated
that mechanistic and clinical studies do suggest an inde-
pendent effect. The experts hypothesised that insoluble
UFP may accumulate and remain in the lungs or second-
ary target organs for over 6 months, potentially leading to
cardiovascular effects. Several experts also mentioned epi-
demiological studies investigating effects of residing in
proximity to major roads, which they considered to be
driven (at least partly) by UFP [43-46]. They reasoned that
the contrasts in UFP concentrations are higher close to
roads than for PM10 and PM2.5. Some experts mentioned
that the database of studies relative to "proximity to
roads" was limited and somewhat inconsistent or that the
contribution of UFP to potential effects was difficult to
disentangle. Lower ratings were mostly motivated by a
lack of data.
Cardiovascular morbidity and respiratory morbidity (excluding lung 
cancer)
Likelihood ratings ranged from low to high, mostly
medium (n = 7) for cardiovascular morbidity. The experts
considered the underlying mechanism to be plausible,
implying that UFP can affect all the elements of the main
triad leading to cardiovascular disease (endothelial dys-
function, thrombosis and plaque destabilization). As for
mortality, the ratings of these long-term exposure effects
on cardiovascular morbidity were only slightly lower than
for the corresponding short-term exposure effects.
The ratings for respiratory morbidity were more variable
across experts (ranging from very low to very high),
though most provided a rating of medium (n = 7). Likeli-
hood of effects on respiratory morbidity were rated
slightly lower compared to cardiovascular morbidity, and
much lower than aggravation of asthma (its related short-
term effects counterpart). As a potential mechanism, the
experts reasoned that respiratory conditions, such as
asthma and COPD, are affected by inflammation, which
in turn can be caused by UFP exposure. This was sup-
ported by evidence from proximity to roads studies,
increasing the confidence of the experts. Furthermore, it
was argued that if cigarette smoke contains a lot of UFP
and can cause COPD or emphysema, then ambient UFP
could play a similar role. However, as for mortality, much
uncertainty remains because effects of UFP cannot easily
be disentangled from those caused by larger particles.
Lung cancer
Ratings for the likelihood of lung cancer effects ranged
from very low to high (mostly medium, n = 6 out of 12).
On the one hand, some experts referred to findings of
excessive lung cancer in humans exposed to fine particles
[47] as well as to the potency of UFP to cause lung cancer
Final likelihood ratings for health endpoints being causally related to long-term UFP exposure Figure 3
Final likelihood ratings for health endpoints being causally related to long-term UFP exposure.Particle and Fibre Toxicology 2009, 6:19 http://www.particleandfibretoxicology.com/content/6/1/19
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in animals. On the other hand it was mentioned that there
are no specific studies on UFP effects and some experts
thought it more likely that larger particles are responsible.
3. Likelihood of different causal pathways leading to a 
cardiac event
In total, six broadly defined causal pathways potentially
explaining the role of UFP in contributing to cardiac
events in humans were discussed and rated by the experts,
represented together in figure 5. The elicitation was based
upon two graphical displays of these mechanisms. Figures
6 and 7 in the appendix show the original drawings as pre-
sented to the experts during the meeting. These figures
purposely provide a simplified representation of a highly
complex reality. As a result, many important elements,
such as the exact mechanisms of oxidative stress, tran-
scription factors, or inflammatory mediators, could not be
included in detail. The six pathways are further described
in the appendix. The likelihood ratings of the experts for
each of these pathways are presented below. In all of these
Final likelihood ratings for causal pathways relating UFP exposure to acute cardiac events Figure 4
Final likelihood ratings for causal pathways relating UFP exposure to acute cardiac events.Particle and Fibre Toxicology 2009, 6:19 http://www.particleandfibretoxicology.com/content/6/1/19
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Schematic overview of causal pathways potentially explaining the manifestation of acute cardiac events caused by UFP exposure Figure 5
Schematic overview of causal pathways potentially explaining the manifestation of acute cardiac events caused 
by UFP exposure.Particle and Fibre Toxicology 2009, 6:19 http://www.particleandfibretoxicology.com/content/6/1/19
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ratings, a causal relationship between UFP and cardiac
events was assumed. The ratings were thus conditional on
causality.
Pathway 1a (airway inflammation – plaque rupture)
As shown in figure 4, pathway 1a was given the highest
likelihood ratings by the experts: high (n = 10 out of 12)
to very high. The experts thus had little doubt that this
pathway explains at least part of the cardiovascular effect
of UFP. Experts mainly motivated their ratings by referring
to the large body of studies from different disciplines,
which consistently point into the same direction. All steps
within this causal pathway were considered to be proven,
mainly in animal studies with more limited support from
human data (e.g. from the AIRGENE project [48] and
[49]).
Pathway 1b (translocation of particles – plaque rupture)
The experts rated the likelihood of this pathway from
(very) low to medium, referring to the limited evidence
that exists on the subject (mainly animal studies). Data
also suggest that only a small proportion of UFP translo-
cate. Most experts did believe that translocation occurs,
but the dose might be too low to cause cardiac effects.
Others argued that UFP might accumulate and cause
effects, but these would probably take some years to
develop (long-term effects).
Pathway 1c (respiratory reflexes – ANS – plaque rupture)
Figure 4 shows the rather broad range of ratings for path-
way 1c (ranging from very low to high; with half of the
experts rating medium), pointing at significant uncertain-
ties and differences of opinion amongst experts. There
exists a rather large body of evidence in animals for respi-
ratory reflexes, but none in humans. In general, therefore,
experts considered this pathway as uncertain and hence its
likelihood as difficult to judge.
Pathway 2a (respiratory inflammation – ANS – arrhythmia)
The likelihood ratings for pathway 2a ranged from low to
high, mostly medium (n = 6). Some experts doubted the
importance of the ANS in relating UFP exposure to cardiac
events as such, but noted that, if an effect on the ANS
would occur, UFP induced inflammation would probably
be its most likely cause. This explains why pathway 2a is
rated slightly higher than 2b and 2c. Further evidence
causing the experts to judge this pathway rather unlikely
came from UFP studies in Edinburgh, in which healthy
and diseased volunteers have been exposed to diluted die-
sel engine exhaust with and without UFPs (Mills et al., in
preparation; [50]). These studies showed no effect on
HRV despite a significant increase in cardiac events. How-
ever, some clinicians reasoned that this pathway is possi-
ble nonetheless, based on the plausibility of irritation of
autonomic receptors by inflammatory mediators.
Pathway 2b (translocation of particles – ANS – arrhythmia)
The likelihood of pathway 2B was rated very low to
medium by the experts, with 10 experts providing a low or
very low rating. Especially clinicians were highly sceptical
towards the likelihood of this pathway. Evidence was
judged insufficient, and the amount and rate of transloca-
tion was not considered to be able to explain the onset
and magnitude of the cardiac effects found.
Pathway 2c (respiratory reflexes – ANS – arrhythmia)
The likelihood of pathway 2c was rated low by most of the
experts (n = 6), but also medium and high by some. Moti-
vation for a low likelihood mainly involved the limited
data available. However, some epidemiologists argued
that several studies give proof for the different steps defin-
ing this pathway, and most clinicians found this mecha-
nism to be plausible even if there is too little evidence to
prove it.
Discussion
A multidisciplinary European expert team rated the likeli-
hood of causal relationships between ambient UFP expo-
sure and selected health endpoints, including all-cause
mortality and cardiovascular and respiratory hospital
admissions. The experts also rated the likelihood of
potential underlying causal mechanisms that may explain
an effect of UFP on cardiac events. The likelihood of a
causal relationship between short-term UFP exposure and
all-cause mortality, cardiovascular and respiratory hospi-
tal admissions, aggravation of asthma symptoms and lung
function decrements was rated as medium to high by
most of the experts. The ratings for long-term exposure
related effects were only slightly lower compared to short-
term related effects for mortality and cardiovascular hos-
pital admissions; long-term exposure effects on respira-
tory morbidity and lung cancer were mainly rated
medium. Divergence of opinions among experts was
larger for respiratory morbidity and lung cancer than for
total mortality and cardiovascular morbidity. There does
not appear to be much difference between the ratings of
epidemiologists, toxicologists and clinicians, although
our sample size is too small to make any definitive state-
ments about potential interdisciplinary variation. Moreo-
ver, even though most experts were nominated in one
specific category, they might in reality represent the views
of multiple disciplines.
From the evaluated causal pathways relating UFP expo-
sure to cardiac events, the pathway involving respiratory
inflammation and subsequent thrombotic effects (path-
way 1a) was rated most likely. All experts rated the likeli-
hood of this pathway as high or very high. This pathway
is most often described in the literature, and the specific
steps of the causal pathway were all considered plausible.
The lowest ratings were given to the pathway 2b describ-Particle and Fibre Toxicology 2009, 6:19 http://www.particleandfibretoxicology.com/content/6/1/19
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ing translocation of particles affecting the autonomic
nervous system (ANS), which in turn may lead to changes
in HR, HRV or arrhythmia. For this specific pathway, evi-
dence was considered missing or even contradictory, and
the plausibility was thought to be limited. Other path-
ways involving effects on the ANS (1c, 2a and 2c) were
given slightly higher ratings. However, overall, the experts
expressed the route via plaque rupture/thrombosis to be
more likely to cause a cardiac event than the route via the
effects on the ANS. Although we confined the elicitation
to mechanisms potentially explaining cardiac effects,
(part of) the same or similar mechanisms may also
explain the onset and progression of other adverse health
effects. Similarly, parts of the proposed mechanisms
might also play a role in explaining adverse health effects
related to exposure to coarser fractions of PM, other com-
ponents or air pollution or engineered nanomaterials
[1,11,19,51].
The experts were explicitly asked to rate the likelihood of
a causal relationship, given the available evidence (i.e.
they were not asked to rate the availability of evidence).
The general lack of consistent evidence made the process
of rating a challenging task for most experts. Complicating
factors included that information had to be extrapolated:
from animal to humans; from larger particles (PM2.5 and
PM10) to UFP; from high doses as frequently used in
experimental studies to concentrations similar to those in
ambient air [6]; from (time-series) monitoring measure-
ments to personal exposure; and from the studied sample
of the population to the general population. Additionally,
experts indicated the uncertainty related to lag times and
presence or absence of a threshold of effect, accuracy of
death certification and hospital admissions, susceptible
groups, as well as variation in the analytical methods
employed [7]. The presence of these uncertainties sup-
ports the use of formal expert elicitation to assess the like-
lihood of causality and causal mechanisms.
The likelihood of a causal association between UFP and
mortality was assessed as being lower than in a recent US
expert panel assessing causality of PM2.5 and mortality
[22]. In that study, 10 out of 12 experts rated the likeli-
hood of causality as very high, one as high and one as
medium (quantitative numbers translated into our
schema using the nearest number). In our study, likeli-
hood of a causal association between UFP and mortality
was rated high or very high by 4 out of 12 experts,
medium by 7 experts, and low by one. Besides being
based on higher evaluations of the likelihood of a causal
relation for PM2.5 as compared to UFP, the differences
may also be partly due to the composition of the panel or
other methodological differences between the studies.
Furthermore, it is likely that the larger database of studies
on long-term exposure of PM2.5 compared to UFP played
an important role in the higher rating in the US study.
There was no overlap between experts participating in the
US study and those participating in our study.
The overall medium to high likelihood rating of causality
of health effects of UFP exposure and the high likelihood
rating of at least one plausible mechanism explaining
associations between UFP and cardiac events, support the
potential usefulness of inclusion of UFP in future Health
Impact Assessments (HIA) involving air pollution. The
elicited concentration-response functions that were
derived on the second day of our expert meeting (Hoek et
al. submitted) can be used as input for these assessments.
HIAs usually assess the health effects of particulate matter
air pollution based on concentration-response functions
as derived for e.g. PM2.5 or PM10, [52] which as such func-
tion as a proxy for other (correlated) components of the
air pollution mixture. However, PM2.5 and PM10 concen-
trations do not capture variations of UFP very well; hence
the potential effects of UFP have been largely ignored.
Especially in the assessment of transport-related air pollu-
tion this may be a limitation, as motorized transport
affects UFP concentrations more than PM2.5  or PM10.
Therefore, in order to provide improved estimates of the
health effects of air pollution, UFP effects should be
assessed separately. As such we have made a first attempt
to fill an important hiatus in current HIA of air pollution.
Compared to the evidence for PM2.5, there is still consid-
erable uncertainty, calling for additional research. The
results of this expert elicitation give a starting point for
evaluating which aspects of the pathways could be
focused on in further research.
We have only presented the final likelihood ratings, which
were given after plenary discussion, while the individual
initial ratings were given before any discussion on the par-
ticular question. In a post-hoc comparison of final and
initial ratings, we saw that – although most experts stuck
to their initial judgments – some did occasionally adjust
their rating after group discussion. In those cases, the rat-
ings were usually not changed more than one point (rat-
ing class) and mostly in the direction of the mean. We
have no reason to believe this to be an effect of 'peer pres-
sure'. Rather, adjustments to initial ratings were brought
about by considering new arguments, as indicated in the
written motivations, or by harmonization of interpreta-
tion of the question within the expert panel, which we
think both have increased the value of the final ratings.
We did not aim at reaching consensus among the experts.
Given the limited state of knowledge in the field, the sci-
entific debate should consider the full spectrum of reason-
able hypotheses, and forcing conversion to a consensus
view may lead to putting more weight to one of the
hypotheses than warranted. Closure of the scientific
debate should be based on empirical evidence and not inParticle and Fibre Toxicology 2009, 6:19 http://www.particleandfibretoxicology.com/content/6/1/19
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a negotiated consensus amongst expert judgments. Also,
different estimates are often based on completely different
motivations, and a central 'consensus' estimate might no
longer relate clearly to anyone's viewpoints. Finally, we
realize that we have been able to obtain a multidiscipli-
nary sample of respected scientific opinions, but not a rep-
resentative set of all opinions available on the subject
matter in the scientific community. Possibly, the nomina-
tion procedure has biased the selection towards 'believers'
of UFP as a causal agent. Nonetheless, the set of expert
judgments we have assembled is expected to collectively
enhance scientific understanding of the (likelihood of)
health effects related to UFP exposure and helps to clarify
the current state of knowledge.
Conclusion
The overall medium to high likelihood rating of causality
of health effects of ultrafine particle exposure and the high
likelihood rating of at least one plausible causal mecha-
nism explaining associations between ultrafine particles
and cardiac events, supports the need to consider inclu-
sion of ultrafine particles in future health impact assess-
ments of (transport-related) air pollution.
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Appendix: Potential causal mechanisms for UFP 
exposure and cardiac events
The initial (patho)physiological effects of UFP can
broadly be divided into:
A. Respiratory and/or systemic inflammation;
B. Translocation of particles to the bloodstream; and
C. Respiratory reflexes and consequent dysfunction of
the autonomic nervous system (ANS)
These three responses can all lead to a cardiac event,
roughly caused by 2 different mechanisms:
1) Through a series of processes resulting in plaque
rupture and thrombosis;
2) By affecting the ANS, which may lead to changes in
HR, HRV or Arrhythmia.
Combining these potential sub-pathways, in total six
broad (partly overlapping and all potentially co-existing)
pathways can be identified (figures 6 and 7 – graphical
versions as presented to the experts). These pathways are
shortly described below.
Lung deposition
All pathways considered here start with deposition of
UFP, which enter the lungs by millions with every breath
[4], on the respiratory epithelium. The smaller the parti-
cle, the higher the probability that it hits the epithelium of
a lung structure [6]. The efficiency of deposition, along
with the large surface area and potential of bound transi-
tion metals are thought to be very important for initiating
a physiological response [11]. Many of the effects occur-
ring straight after deposition, such as retention, clearance,
dis-aggregation and distribution, are not yet fully under-
stood [4,6,12], but the initial interaction between parti-
cles and the surfactant film is considered to set off a
complex immunological cascade in the lung [4]. There is
convincing evidence that UFP are able to retain in the epi-
thelium and interstitium (the space in between cells) for
prolonged periods of time [6], potentially leading to
endothelial dysfunction (Mills et al. in preparation, [53]).
Pathway 1a
Pathway 1a describes the mechanism in which UFP trigger
an acute inflammatory response in the lungs through oxi-
dative stress via activation of oxidative stress-responsive
transcription factors [12,19]. The inflammation can be
mediated by transition metals (derived from fuel combus-
tion) that are bound on the reactive surface of these parti-
cles, but there are potentially also non-transition metal-
mediated pathways to inflammation, relating to the small
size and large reactive surface of UFP. Cells such as macro-
phages, epithelial cells and neutrophilic granulocytes are
subsequently activated and can produce reactive oxygen
species (ROS), free radicals, hydrogen peroxide, etc, to
attack the UFP. This process leads to secretion of cytokines
and chemokines into the affected area. Subsequently, aParticle and Fibre Toxicology 2009, 6:19 http://www.particleandfibretoxicology.com/content/6/1/19
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cascade of events may trigger changes in the control of
blood clotting and promote pulmonary or systemic
inflammation and atherosclerosis. This can in turn lead to
acute cardiovascular responses such as increased blood
pressure, thrombosis, and eventually a cardiac event. This
pathway, which was the one originally proposed by
Seaton and co-workers [16], is generally considered
important, based on both in vitro and in vivo studies [1].
Pathway 1b
In recent years, several studies have shown that a fraction
of UFP can, unlike coarse or fine particles, penetrate
deeply into the lung interstitium and evade clearance
mechanisms [1]. As such, UFP may directly enter into the
blood stream through phagocytosis by macrophages or
endocytosis by the epithelial and endothelial cells. Subse-
quently UFP can translocate to extrapulmonary sites such
as bone marrow, lymph nodes, liver, heart, spleen, and
brain [1,4,8,11]. Evidence is however conflicting with
regard to the extent of this translocation and its patholog-
ical impact [6,10], which is assumed to be dependent on
particle size, chemical characteristics, and surface features
[1]. The circulating particles may cause local oxidative
stress that could destabilize atherosclerotic plaques and,
similar to the mechanisms described for pathway 1a, set
of a cascade of reactions involving plaque rupture, throm-
bosis and eventually acute cardiac events [1,11,54]. Oxi-
dative stress can increase the permeability of the lung
epithelium and thereby further increase potential for
translocation of particles [12]. Alternatively, particles may
Schematic overview of causal pathways potentially explaining the manifestation of acute cardiac events through thrombosis and  plaque rupture, caused by UFP exposure Figure 6
Schematic overview of causal pathways potentially explaining the manifestation of acute cardiac events 
through thrombosis and plaque rupture, caused by UFP exposure.Particle and Fibre Toxicology 2009, 6:19 http://www.particleandfibretoxicology.com/content/6/1/19
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cause a direct effect to the heart if transferred there by the
bloodstream [11]. Furthermore, other molecules that are
produced in the lung as a response to particles may also
enter the interstitium and the bloodstream, potentially
leading to various negative systemic effects [12].
Pathway 1c
A third hypothesis with regard to initiation of a physical
response after exposure to UFP involves the suggested
ability of UFP to stimulate nerve endings in the walls of
the airways causing direct respiratory reflexes. Such stim-
uli may result in dysfunction of the autonomic nervous
system (ANS) and cardiovascular autonomic dysfunction
[1]. The most described effect that is assumed to be the
result of this process is disruption of the cardiac rhythm
resulting in (fatal) arrhythmia [1,7,11] (pathway 2c).
However, effects on the ANS may also eventually lead to
acute cardiovascular responses and a cardiac event
[13,55,56] through the innervation of the heart. The latter
mechanism is represented by pathway 1c.
Pathway 2a
Besides potentially resulting from direct stimulus of lung
nerve ending, effects on the ANS can also be a response to
respiratory inflammation as a result of cytokine release in
an acute phase reaction [8]. This can potentially lead to
changes in heart rate (HR), heart rate variability (HRV) or
even arrhythmia, which suggests another pathway
towards cardiac events [7,11]. Overall, evidence on the
effects of particulate air pollution on blood pressure and
HR remains inconsistent [8]. Effects are probably mainly
or only possible in susceptible patients with pre-existing
Schematic overview of causal pathways potentially explaining the manifestation of acute cardiac events through effects on the  autonomous nervous system, caused by UFP exposure Figure 7
Schematic overview of causal pathways potentially explaining the manifestation of acute cardiac events 
through effects on the autonomous nervous system, caused by UFP exposure.Particle and Fibre Toxicology 2009, 6:19 http://www.particleandfibretoxicology.com/content/6/1/19
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heart disease such as MI and chronic heart failure [7].
Increases in HR in response to air pollution are further-
more mostly found in people with high blood viscosity
[12]. However, as yet much remains to be elucidated and
further studies are needed to investigate UFP (or total PM)
related ANS effects.
Pathway 2b
Some studies, as reviewed by Oberdörster [19], have
investigated the potential of UFP to be translocated to the
brain through neuronal uptake via transcytosis. The olfac-
tory nerve is considered to be the most likely pathway for
the transport of particles inhaled through the nose. How-
ever, it is not yet known whether or not these translocated
UFP cause injury or toxicity to the brain [1,19]. In theory,
they may affect the ANS, which may in turn affect cardiac
rhythm and lead to a cardiac event, again mainly or only
in susceptible patients [7].
Pathway 2c
Direct respiratory reflexes, as described for pathway 1c,
may lead to dysfunction of the ANS and cardiovascular
autonomic function, which can in turn lead to disruption
of the cardiac rhythm and (fatal) arrhythmia [1,8,11] in
susceptible patients. Disturbances in the control of heart
rate in response to respiratory reflexes induced by particu-
late pollution were originally suggested by two observa-
tional studies [57,58], but experimental animal evidence
also supports this hypothesis [7].
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